Prosecution Insights
Last updated: October 25, 2026

Encodia Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

Encodia Inc. has 10 pending office actions in Biotechnology & Pharmaceuticals. The portfolio includes 10 distinct examiners and 7 distinct art units. OLSON, ALEXANDRA NADINE is the busiest examiner, with 1 pending matter, so the actions are broadly distributed among examiners while some art units receive more than one matter.

The portfolio benefits from centralized tracking of claim terms, specification support, technical evidence, and response status. Because the examiner count exceeds the art-unit count, counsel may identify art-unit-level themes while still preparing examiner-specific arguments. No single examiner controls multiple pending matters in the supplied data, so each response should be independently reviewed against its own record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

10
Total Pending OAs
10
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (50%)
4
Medium (40%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (20%)
§112 only1 (10%)
Double-patenting + other2 (20%)
Multi-statute (no §101)5 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OLSON, ALEXANDRA NADINE 1 100.0% +0.0%
YOUNG, BRIAN ELLIS 1 65.0% +28.3%
LANKFORD JR, LEON B 1 70.0% +31.5%
BEANE, RANDALL L 1 32.9% +36.2%
HIBBERT, CATHERINE S 1 58.8% +48.6%
CHIU, MAY LEUNG 1 43.3% +26.1%
PHAM, KHAI QUYNH TIEN 1 0.0% +0.0%
DAUNER, JOSEPH G 1 57.0% +35.3%
ADAMS, MICHELLE 1 58.8% +40.4%
RAYMONDA, MATTHEW HAROLD 1 40.0% +47.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18658862 HIGH-THROUGHPUT SEROTYPING AND ANTIBODY PROFILING ASSAYS OLSON, ALEXANDRA NADINE —

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17272236 PROXIMITY INTERACTION ANALYSIS RAYMONDA, MATTHEW HAROLD 2d overdue
18499944 METHODS FOR BIOMOLECULE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS LANKFORD JR, LEON B —
18201129 POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS BEANE, RANDALL L —
18297914 ARGININE MODIFICATION AND CONJUGATION METHODS HIBBERT, CATHERINE S —
18120676 REAGENT CARTRIDGE AND TEMPERATURE CONTROL SYSTEM CHIU, MAY LEUNG —
18065282 METHODS FOR PROTEIN IDENTIFICATION BASED ON ENCODING REACTIONS PHAM, KHAI QUYNH TIEN —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17272236 PROXIMITY INTERACTION ANALYSIS RAYMONDA, MATTHEW HAROLD 2d overdue
17606759 METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE ADAMS, MICHELLE 6d
18586030 SEQUENTIAL ENCODING METHODS AND RELATED KITS YOUNG, BRIAN ELLIS —
18499944 METHODS FOR BIOMOLECULE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS LANKFORD JR, LEON B —
18201129 POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS BEANE, RANDALL L —
18297914 ARGININE MODIFICATION AND CONJUGATION METHODS HIBBERT, CATHERINE S —
18120676 REAGENT CARTRIDGE AND TEMPERATURE CONTROL SYSTEM CHIU, MAY LEUNG —
17611523 METHODS AND RELATED KITS FOR SPATIAL ANALYSIS DAUNER, JOSEPH G —

Top Art Units

Art UnitApps
1684 4
1657 1
1654 1
1658 1
1758 1
1682 1
1797 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18658862 HIGH-THROUGHPUT SEROTYPING AND ANTIBODY PROFILING ASSAYS OLSON, ALEXANDRA NADINE 1684 §103Other Non-Final OA — Pending May 08, 2024
18586030 SEQUENTIAL ENCODING METHODS AND RELATED KITS YOUNG, BRIAN ELLIS 1684 §102§103DP Non-Final OA — Pending Feb 23, 2024
18499944 METHODS FOR BIOMOLECULE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS LANKFORD JR, LEON B 1657 §102§103 Non-Final OA — Pending Nov 01, 2023
18201129 POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS BEANE, RANDALL L 1654 §102§103§112 Non-Final OA — Pending May 23, 2023
18297914 ARGININE MODIFICATION AND CONJUGATION METHODS HIBBERT, CATHERINE S 1658 §103§112 Non-Final OA — Pending Apr 10, 2023
18120676 REAGENT CARTRIDGE AND TEMPERATURE CONTROL SYSTEM CHIU, MAY LEUNG 1758 §102§103§112 Non-Final OA — Pending Mar 13, 2023
18065282 METHODS FOR PROTEIN IDENTIFICATION BASED ON ENCODING REACTIONS PHAM, KHAI QUYNH TIEN 1684 §102§103§112DP Non-Final OA — Pending Dec 13, 2022
17611523 METHODS AND RELATED KITS FOR SPATIAL ANALYSIS DAUNER, JOSEPH G 1682 §103 Non-Final OA — Pending Nov 15, 2021
17606759 METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE ADAMS, MICHELLE 1797 §112 Non-Final OA 6d Pending Oct 26, 2021
17272236 PROXIMITY INTERACTION ANALYSIS RAYMONDA, MATTHEW HAROLD 1684 §103§112 Non-Final OA 2d overdue Pending Feb 26, 2021

Managing Encodia Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Encodia Inc. have?

Encodia Inc. has 10 pending office actions as of October 2026, spread across 7 art units and 10 examiners.

Which USPTO examiner handles the most Encodia Inc. applications?

Alexandra Nadine Olson has the most, with 1 of Encodia Inc.'s pending office actions.

What technology area are Encodia Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month